Loading…
Anlotinib vs placebo as third- or further-line treatment for patients with small cell lung cancer: a randomised, double-blind, placebo-controlled Phase 2 study
Cheng, Ying, Wang, Qiming, Li, Kai, Shi, Jianhua, Liu, Ying, Wu, Lin, Han, Baohui, Chen, Gongyan, He, Jianxing, Wang, Jie, Lou, Donghua, Yu, Hao, Wang, Shanchun, Qin, Haifeng, Li, Xiaoling
Published in British journal of cancer (03.08.2021)
Published in British journal of cancer (03.08.2021)
Get full text
Journal Article
Loading…
Dose–response assessment by quantitative MRI in a phase 1 clinical study of the anti-cancer vascular disrupting agent crolibulin
Lorza, Andres M. Arias, Ravi, Harshan, Philip, Rohit C., Galons, Jean-Philippe, Trouard, Theodore P., Parra, Nestor A., Von Hoff, Daniel D., Read, William L., Tibes, Raoul, Korn, Ronald L., Raghunand, Natarajan
Published in Scientific reports (02.09.2020)
Published in Scientific reports (02.09.2020)
Get full text
Journal Article
Loading…
The contribution of dietary and plasma folate and cobalamin to levels of angiopoietin-1, angiopoietin-2 and Tie-2 receptors depend on vascular endothelial growth factor status of primary breast cancer patients
Pirouzpanah, Saeed, Varshosaz, Parisa, Fakhrjou, Ashraf, Montazeri, Vahid
Published in Scientific reports (16.10.2019)
Published in Scientific reports (16.10.2019)
Get full text
Journal Article